Xandar Kardian, a Toronto-based company has announced an integrated partnership with Eatontown, N.J.-based Caregility. The former is prominent in developing radar signal processing technology for presence detection and vital sign monitoring; while the latter is an enterprise telehealth provider dedicated to connecting care for patients and clinicians.
For the first time ever, Xandar Kardian says it will embed its radar technology into a partner’s existing product line. Here, it will join Caregility’s Best in KLAS Caregility Cloud virtual care ecosystem to create a solution wholly focused on optimizing acute patient care. Xandar Kardian and Caregility will debut the solution at the upcoming 2023 HIMSS Global Health Conference and Exhibition. The event will take place in Chicago, April 17-21.
Improving the Healthcare Experience
Xandar Kardian’s partnership with Caregility will begin rolling out across facilities in spring. Here, the partnership combines the capabilities of Xandar Kardian’s patient vital sign monitoring technology through radar signal processing with Caregility’s expertise in virtual clinical workflows and patient analysis to optimize remote acute care. The integration will increase capacity for staff to virtually observe and manage higher-acuity patients in a traditional med-surg environment. It will also help leverage a workflow and connectivity they are already familiar with. Most importantly, the innovative solution will empower clinical teams with new ways to deliver care. Per a statement, this is especially crucial as chronic workforce challenges persist and staff and consumer expectations evolve.
“Our best-in-class radar technology has the ability to completely transform the future of patient monitoring, especially as telehealth and hybrid healthcare models continue to strengthen as paths for patients to receive acute medical attention,” says Sam Yang, CEO and founder of Xandar Kardian. “We take great pride in our technology’s ability to proactively diagnose and mobilize critical medical care; and we couldn’t ask for a better partner than Caregility to enable our radar technology to be implemented on a wider scale.”
Also Watch: Caregility’s Mike Brandofino on the Rise of Virtual Medicine
Implementing the Radar Technology
Xandar Kardian’s radar-based solutions operates without requiring cameras, wearables or any patient contact whatsoever. It can also provide critical early deterioration detection in all varieties of healthcare settings. This ranges from inpatient facilities to virtual and home-health care. Xandar Kardian’s sensors can also measure 6000+ RHR (Resting Heart Rate) & RR (Respiratory Rate) readings a day, as opposed to a traditional hospital setting. In the latter, staff measures these vital signs manually on a a much less frequent basis. The benefit for Caregility is that the AI-driven radar solution also offers autonomous continuous patient monitoring “on demand” through Xandar Kardian’s data dashboard. It thus expands the capability of their devices and differentiating their own products and solutions.
“We are constantly looking for new innovations and best-in-class solutions to add to Caregility Cloud, our virtual care platform; as we strive to empower clinicians to deliver better care,” explains Pete McLain, chief strategy officer at Caregility. “We are excited about Xandar Kardian’s FDA-cleared radar sensing device. And[we] believe it will accelerate access to meaningful trends in patient data to support timely clinical actions with care for patients. And patients love it as it is non-invasive, contactless and private.”
Interested in more news like this? Sign up for our e-newsletter today!